News & Insights

ObvioHealth and GI Alliance Partner to Bring Better GI Care to Patients

ObvioHealth, a globalvirtual research organization (VRO), and GI Alliance, one of the nation'slargest independent gastroenterology services organization, jointly announce anew partnership to create better clinical trial experiences through the use ofdecentralized clinical trial designs.

3 Reasons Why Patients Prefer Virtual Clinical Trials

Site visits pose many problems for clinical trial sponsors, especially during the ongoing pandemic. However, research can continue with minimized risk for all involved when done virtually.

ObvioHealth and Hospital Paris Saint-Joseph Announce Partnership to Track COVID-19 in Oncology Patients

ObvioHealth, a full-service virtual research organization (VRO), announces today a partnership with La Foundation Hôpital Paris Saint Joseph to monitor COVID-19

The Critical Need for Virtual COVID-19 Clinical Trials and Patient Training

COVID-19 drug development has brought a unique set of clinical challenges, virtual patient training and decentralized trials can be part of the solution.

ObvioHealth Secures $17 Million in Latest Investment Round

ObvioHealth, a leading virtual health research organization or VRO, announced today it has raised $17 million in its latest round of financing. This round of financing comes on the heels of a global alliance with a strategic partner announced in March.

Virtual Research: 5 Advantages of the New Normal

More now than ever, virtual research methods are being adopted by those in the scientific community. The advantages of “going digital” are simply too great to pass up.

Enrollment Completed for Virtual Dermatology Study

ObvioHealth is excited to announce the completion of enrollment for its latest completely virtual research study. Our digital, disruption-free, approach to recruitment allowed participants to enroll from the safety of their homes.

Coronavirus Outbreak: Medical Staff Vulnerable, Telemedicine the Solution?

Medical personnel working on the frontline to prevent the spread of the COVID-19 (coronavirus) are susceptible to infection, we believe telemedicine can help to mitigate this risk.

ObvioHealth Launches Virtual COVID-19 Symptoms & Immune Response Registry

Singapore and New-York, 2 April 2020 – ObvioHealth, a digital research company, announces the launch of a registry to monitor COVID-19 prevalence, symptoms and immune response in the United States over the coming 12 months.

Infographic: The People-Centric Path to Better Data

A research study designed around the needs of its participants is more likely to deliver better data, a product of optimized compliance and engagement. By pairing a versatile digital solution with an accommodating protocol design, ObvioHealth can offer maximum convenience to those who matter most: the people who produce the data. The result? A collection of real-world data points and enhanced insights.

Patient Interactions: Sustained Engagement via Digital Communication

In the clinical trial space, patient concerns that must be addressed with tact. Whether delivering potentially life-altering news, or discussing a health-related concern, I find digital interaction to be the most prudent approach to sustaining engagement and reducing dropout. Here are five real-life examples of this strategy at-work.

Real World Data and Evidence Revolutionize Clinical Research

The U.S. FDA is aware the drug approval process can often be strenuous, consuming large amounts of time and money. That’s why they’ve made a commitment to consider real-world evidence in the approval of new drug indications resulting in a more efficient approach for manufacturers.

Going Virtual: Succeeding Where Traditional Clinical Trials Fail

ObvioHealth, a digital CRO, recently completed a clinical trial solely using a virtual site model (no physical site visits) which would have likely proved futile in the traditional study format, of which requires multiple site visits. This article will further analyze the rationale behind this claim.

PI Perspective: Our Formula to Curb Clinical Trial Dropouts

Our team recently completed a clinical trial tasked with measuring the efficacy of a dietary supplement as an intervention for adults with an elevated blood pressure, or stage I hypertension. By employing a hybrid study model, sustaining patient engagement, and reducing resources required of the patient and study team, we successfully beat the dropout allowance.

Infographic: Resource Consumption by Clinical Trial Type

All clinical trials require resource consumption from both the study team and participant. The following infographic will detail the differences in resources required in the digital (hybrid) model compared to that of the traditional “brick and mortar” model.

An Alternate Approach to the Traditional Recruitment Nightmare

Digital patient-centric clinical trials (PCT) are often carried out in the hybrid setting (minimizing site visits and maximizing the use of a virtual site), or the site-less setting (solely using the virtual site). The pairing of a digitalized PCT with social media targeting increases the probability of successful enrollment.

New Clinical Trial Begins to Measure Efficacy of an Herbal Blend on Menopausal Symptoms

*UPDATE: Enrollment has been filled for this study.*
‍We’re pleased to announce recruitment is underway for our latest research study.

PI Perspective: Patient Engagement in a Digital Trial

I’ve been involved in clinical research in the traditional “brick and mortar site” setting, and now, in my current role as a principal investigator (PI) for ObvioHealth, in the digital “virtual site” setting.

Diversity in Clinical Trial Enrollment: Exploring the Roadblocks to Minority Participation in Clinical Research

In the first part of our two-piece series exploring minority participation in clinical trial research, we examine the numerous challenges to securing diversity in clinical trials, and the consequences of primarily white patient populations.

4 Scenarios for Using Mobile Clinical Trials

Digital technology can now enable collecting data from participants in their homes, during their everyday lives, instead of inconvenient, costly trips to the clinic. It’s as simple as having a smart phone.

12 questions to ask before participating in a clinical research trial

There are more than 270,000 clinical research trials going on in the U.S. and other countries currently listed on ClinicalTrials.gov. These trials are helping to advance medial research for better treatments of diseases and conditions. However, before decided to participate in one, there are a number of items to consider first.

Obvio Health Raises $3M in Series A Funding

Obvio Health Inc, a company offering 100% mobile & “site-less” clinical trials, announced today a $3 million series A financing round, led by TKS I, a life science and healthcare focused venture fund.

If I participate in a clinical trial how will my data be used?

Data collected from you as a participant is called individual participant data (IPD), that information is transformed into de-identified data when researchers do their analyses, meaning the ability to determine the identity of an individual participant is removed from the data.

ObvioHealth Announces Mobile Application to Transform Clinical Studies

ObvioHealth, a global medical technology company, announces the launch of its mobile application for site-less clinical studies.

Compliance Problems? 5 Ways Digital Tech Can Help

Inconvenience to the subject and infrequent engagement with the study team often lead to low compliance. Digital technology, such as ClaimIt, makes it easier for subjects to adhere to the protocol.

3 Ways Digital Clinical Trials Improve Diversity

Integrating mobile technology into study design, takes communication from static start-and-stop moments at site visits, to real-time engagement between participants and researchers.

Infographic: Digital vs. Traditional Clinical Trial Design

Digital, or virtual, clinical trials are conducted in a much different format than that of the traditional “brick and mortar” model.